Longevity, metabolic health, and urological wellness — physician-led. Periodic articles + audio capsule.
May 27, 2026
•
4 min read
A mid-40s man comes in for tendons. The fatigue is an aside. Every panel runs reassuring. The diagnosis is one altitude lower than any panel was measuring.
May 22, 2026
3 min read
Retatrutide's pivotal obesity trial read out as strong as the headlines say — 28.3% weight loss. What's real, what's still fine print, and where it fits.
May 6, 2026
12 min read
A triple-agonist is approaching FDA approval. It won't replace tirzepatide for most of our weight-management folks. It will solve a specific problem for some of them — and we already know who.
Apr 28, 2026
Issue 01 · April 28, 2026
